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Abstract
Part B of the Trail Making Test (TMT-B) is one of the most widely used neuropsychological tests of “executive”
function. A commonly held assumption is that the TMT-B can be used to detect frontal executive dysfunction. However,
so far, research evidence has been limited and somewhat inconclusive. In this retrospective study, performance on the
TMT-B of 55 patients with known focal frontal lesions, 27 patients with focal non-frontal lesions and 70 healthy controls
was compared. Completion time and the number of errors made were examined. Patients with frontal and non-frontal
lesions performed signiﬁcantly worse than healthy controls for both completion time and the number of errors. However,
there was no signiﬁcant difference for both completion time and the number of errors when patients with frontal and
non-frontal lesions were compared. Performance was also not signiﬁcantly different between patients with focal lesions
within different regions of the frontal lobe (orbital, left lateral, right lateral, medial). Our ﬁndings suggest that the TMT-B
is a robust test for detection of brain dysfunction. However, its capacity for detecting frontal executive dysfunction
appears rather limited. Clinicians should be cautious when drawing conclusions from performance on the TMT-B alone.
(JINS, 2015, 21, 169–174)
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INTRODUCTION
The Trail Making Test (TMT; Army Individual Test Battery,
1944) is one of the most widely used neuropsychological
tests in the clinical setting, with Part B of the TMT (TMT-B)
the most commonly administered subtest. It is quick and easy
to administer and has been shown to be highly sensitive to
brain dysfunction in a variety of neurological disorders such
as Traumatic Brain Injury and Alzheimer’s Disease (e.g.,
Lange, Iverson, Zakrzewski, Ethel-King, & Franzen, 2005;
Rasmusson, Zonderman, Kawas, & Resnick, 1998). TMT-B
requires subjects to connect a series of 25 encircled numbers
and letters pseudo-randomly arranged on a page in ascending
order, alternating between number and letter (e.g., 1-a-2-b),
as quickly as possible. Completion time is the most frequently
used dependent measure for performance. However, asses-
sing the number of errors made has also been suggested to be
a useful measure (Mahurin et al., 2006; Stuss et al., 2001).
Since its original conception, many different versions of the
task have been developed to accommodate and account for
verbal/visual difﬁculties, physical limitations, and/or age
differences (see Bowie & Harvey, 2006 and Spreen &
Strauss, 1998).
TMT-B is generally regarded as a test of higher-order
executive function (Spreen & Strauss, 1998). Accurate
detection of executive impairment is important for the
clinical management of many common neurological disorders
such as stroke and dementia. A general assumption is that poor
performance on TMT-B can be used as a marker for frontal
lobe dysfunction. Indeed, the TMT-B is often used clinically
for identifying patients with frontal lobe disturbances
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compared with those with non-frontal disturbances (e.g., Delis,
Kaplan, & Kramer, 2001; Ettlin et al., 2000).
Surprisingly, research evidence so far for the speciﬁcity of
the TMT-B in detecting frontal executive dysfunction has
been relatively limited and results have been mixed. The
majority of studies have mainly compared the performance of
patients with frontal lobe lesions with a healthy control group
only (e.g., Davidson, Gao, Mason, Winocur, & Anderson,
2008).
Few studies have directly compared performance between
patients with frontal and non-frontal lesions. In particular, a
seminal study by Stuss and colleagues (2001) found that
patients with frontal lobe lesions were slower at completing
TMT-B compared with healthy controls and patients with
non-frontal brain pathology. Within the frontal lobe patient
group, those with dorsolateral damage were most impaired
while those with inferior-medial damage were least affected.
This is consistent with fMRI ﬁndings which show greater
activity in the left dorsolateral prefrontal region during TMT-B
performance (Moll et al., 2002). Also of interest, they noted
that in their sample only patients with frontal lobe lesions
made more than one error. Stuss and colleagues concluded
that the TMT-B is useful for assessing frontal lobe function
and in particular that error analysis may be a more informa-
tive measure to categorize performance than completion
time. However, the sample of frontal patients included over
35% of patients with bilateral lesions as well as traumatic
lesions. In contrast, the sample of non-frontal patients did not
include bilateral or traumatic lesions, and the sample was
relatively small (n= 13). These factors may have contributed
to the heightened difference in performance found between
the two lesion groups.
In contrast, other studies have not found a difference in
performance between frontal and non-frontal patients on the
TMT-B when comparing completion time data (for a meta-
analysis, see Demakis, 2004). In a study by Reitan and
Wolfson (1995), performance of four patient groups of equal
size that differed in lesion location (frontal vs. non-frontal)
and lateralization (left vs. right) on the TMT-B was com-
pared. Completion time on the TMT-B was not signiﬁcantly
different for frontal versus non-frontal patients or between
left and right lesioned patients. Similarly, in a relatively large
retrospective series of acute stroke patients, no signiﬁcant
difference in performance was observed between frontal and
non-frontal stroke patients (Tamez et al., 2011). However,
neither study investigated error frequency in their analysis or
looked at more speciﬁc neuroanatomical sub-regions within
the frontal lobe (e.g., medial vs. dorsolateral) which Stuss and
colleagues proposed as important discriminating factors. In
addition, neither study included a healthy control group for
comparison.
The aim of our retrospective study was to compare
performance on the TMT-B in a large sample of patients
with focal frontal and non-frontal lesions, and healthy
controls. Importantly, both completion time and error
frequency was examined for any differences in performance
between groups.
METHODS
Participants
Patients assessed in the Neuropsychology Department of the
National Hospital for Neurology and Neurosurgery (London,
UK) were retrospectively screened for study eligibility.
Inclusion criteria for the study were (a) the presence of a
single focal lesion conﬁned to the frontal or non-frontal brain
region due to a cerebrovascular accident, low grade tumor or
meningioma (b) availability of neuropsychological data
which must include TMT Part-B (c) aged between 18 and
80 years (d) no gross perceptual disturbances (i.e., above the
cutoff on the Incomplete Letters subtest of the VOSP), and
(e) absence of psychiatric disorders or previous neurological
disorders. A total of 82 patients with focal unilateral lesions
who met the inclusion criteria were identiﬁed for the
study (55 frontal patients, 27 non-frontal patients). All stroke
and tumor diagnosis was conﬁrmed by clinical neurological
investigations including neuroimaging (MRI or CT). All
tumor patients had undergone resection before neuro-
psychological assessment. We have previously demonstrated
that the grouping together of patients with focal lesions
caused by stroke and various tumors is methodologically
justiﬁable (Cipolotti et al., 2014). Frontal lesions were
reviewed by two independent neurologists from available
MRI (n= 39; T1 weighted images on 1.5T scanners) and CT
scans (n= 16). Lesions were then classiﬁed by standard
laterality (left: n= 28, right: n= 27) and by a more reﬁned
anatomical sub-division of four main subgroups: orbital
(n= 8), left lateral (n= 12), right lateral (n= 12), and medial
(n= 23). The procedure for classifying lesion location is
described in detail elsewhere (Murphy et al., 2013). In addi-
tion, seventy healthy controls who had no prior history of
neurological or psychiatric disorders were also included for
comparison. The study was approved by the local clinical
governance and ethics committees. Some of the data from
these patients were gathered as part of a larger study of frontal
lobe lesions and have been included in previous published
studies (e.g., Robinson, Shallice, Bozzali, & Cipolotti, 2012).
Neuropsychological Assessment
As this was a retrospective study, all participants were
administered a series of cognitive tests at the time of their
neurological investigation. An estimate of pre-morbid opti-
mal level of functioning was obtained using the National
Adult Reading Test (NART) and the Incomplete Letters of
the Visual Object and Space Perception (VOSP) test was
used to assess visual-perceptual functioning. TMT-B was
administered as a part of the assessment, following the stan-
dard protocol (Bowie & Harvey, 2006). Part A of the TMT
was not administered. The two main dependent variables
were completion time in seconds and number of errors.
Completion time was recorded at the time of administration
and the number of errors made was classiﬁed and recorded
retrospectively.
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Statistical Analyses
For analyses of completion time data, an analysis of
covariance (ANCOVA) was used with group (frontal, non-
frontal, healthy control) as the main between subjects factor.
Age and NART scores were entered as covariates of
no interest in the analyses given that age and intellectual
functioning are known to mediate neuropsychological test
performance. The raw completion time measure was trans-
formed using a natural log transformation before analyses to
deal with the signiﬁcant skew in the data. Error data were
analyzed using the χ2 test. Where comparisons contained
cells of size less than 5, the Fisher’s exact test was used. We
divided participants of each group into those who did not
make an error and those who made one or more error to assess
whether one group is more likely to make an error than
another. In view of the ﬁnding by Stuss et al. (2001) that
only patients with frontal lobe lesions made greater than one
error on the TMT, we ran an additional analysis dividing
participants into those who made one error and those who
made more than one error.
We conducted three main analyses. First, we compared
TMT-B performance for each of the two patient groups with
the healthy control group separately. This analysis investi-
gated whether TMT-B could distinguish individuals with
brain impairment from those without, irrespective of lesion
location. Second, we compared performance between the two
patient groups directly to examine whether performance on
the TMT-B is signiﬁcantly different between them. Finally,
we examined possible lateralization or localization effects in
performance for patients with focal lesions in different
regions within the frontal lobe.
RESULTS
All groups were well-matched for age, gender and years of
education (p> .1). Table 1 provides a summary of group
demographic information. There was no apparent difference
between the frontal and non-frontal patient groups in terms of
chronicity or side of injury (p> .1). The time since injury at
assessment was also not signiﬁcantly correlated with TMT-B
completion time (p> .1). On neuropsychological assessment,
there was no apparent difference between groups on the
NART (p> .1) or on a test of visual perception (VOSP,
Incomplete letters, p> .1).
Table 1. Demographic and Neuropsychological Data: Patients and Healthy Controls
N Mean (SD)
Age (years)
Frontal patients 55 46.45 (14.10)
Non-frontal patients 27 45.33 (14.99)
Healthy controls 70 48.44 (14.50)
Gender (M/F)
Frontal patients 30/25 (55%/45%)
Non-frontal patients 14/13 (52%/48%)
Healthy controls 39/31 (56%/44%)
Education (years)
Frontal patients 46 13.43 (3.00)
Non-frontal patients 26 14.62 (3.44)
Healthy controls 52 13.87 (3.03)
Side of injury (left/right)
Frontal patients 28/27 (51%/49%)
Non-frontal patients 18/9 (67%/33%)
Chronicity (months)
Frontal patients 54 15.86 (26.55)
Non-frontal patients 27 12.11 (22.51)
Etiology (low grade tumour/cerebrovascular
accident/meningioma)
Frontal patients 22/18/15 (40%/33%/27%)
Non-frontal patients 14/9/4 (52%/33%/15%)
Full Scale IQ (NART)
Frontal patients 53 108.72 (11.13)
Non-frontal patients 27 105.78 (12.06)
Healthy controls 70 110.50 (9.76)
VOSP incomplete letters
Frontal patients 54 19.57 (0.60)
Non-frontal patients 14 19.50 (0.94)
Note. Despite absolute differences in means, no statistical difference was found between groups for all demographic and neuropsycho-
logical variables.
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Comparison between frontal/non-frontal patients
with healthy controls
For completion time, both frontal (x= 90.31 s; SD= 55.82)
and non-frontal (x= 96.70 s; SD= 58.25) patients were
signiﬁcantly slower on completing the TMT-B compared
with healthy controls ((x= 67.24 s; SD= 24.44); Frontal vs.
Control – F(1,119)=11.48; p< .01; ηp2=0.09; Non-frontal vs.
Control – F(1,93)=11.48; p< .01, ηp2 = 0.11; see Figure 1a).
Similarly, both frontal and non-frontal patients were sig-
niﬁcantly more likely to make an error than healthy controls
(Frontal vs. Control – χ2(1)= 5.07; p< .05; Φ = -0.20;
Non-frontal vs. Control – χ2(1)= 9.26; p< .05; Φ= -0.31).
Figure 1b shows the percentage of participants in each error
frequency category for the three groups. As shown, although
the majority of healthy controls made no errors (87%), 13%
did make an error with one participant (of the total 70)
making two errors. Therefore, making an error in itself does
not necessarily discriminate between those with and without
a focal lesion.
Comparison between frontal and
non-frontal patients
Comparison between the frontal and non-frontal patient
group on completion time for the TMT-B revealed no
signiﬁcant difference (F(1,76)= 0.39; p = .53). In addition
to conventional null-hypothesis signiﬁcance testing, we also
subjected completion time data to Bayesian analysis which is
thought to be able to provide evidence in support of the null-
hypothesis (Gallistel, 2009); in this instance, that completion
time performance for the two patient groups are equivalent.
Analyses yielded odds of 31:1 (weight: 1.50) in favor of the
null-hypothesis. These odds are considered strong and
weights are considered heavy (c.f., Gallistel, 2009).
With regard to errors, there was no signiﬁcant difference
between the frontal and non-frontal groups in the likelihood
of making an error and making no errors (χ2(1) = 1.11;
p = .29). Furthermore, there was also no difference when we
compared the likelihood of these two groups in making one
or more than one error (p= 1.00). In our sample, ﬁve patients
in the frontal group (8%) and four patients in the non-frontal
group (15%) made more than one error.
Comparison between lesion locations for
frontal patients
To examine whether lesion location within the frontal lobe
had an effect on performance on the TMT-B, frontal patients
were divided into separate subgroups based on standard
lesion lateralization (left, right) and by more speciﬁc neuro-
anatomical sub-regions (orbital, left lateral, right lateral,
medial).
Comparison of completion time for the TMT-B between
left ( x= 89.47 s; SD= 30.34) and right (x= 91.25 s; SD=
70.78) frontal patients revealed no signiﬁcant difference
between groups (F(1,49)= 0.01; p = .36). Similarly, no sig-
niﬁcant difference in completion time was found between the
different frontal sub-regions (orbital: x= 81.73 s; SD= 39.77;
left lateral: x= 93.91 s; SD= 47.00; right lateral: x= 102.86 s;
SD= 91.90; medial: x= 85.95 s; SD= 46.67; F(3,47)= 0.67;
p = .58). There was also no signiﬁcant difference in the like-
lihood of making an error between the left and right frontal
patients (χ2(1)= 0.26; p = .61) or between the different sub-
regions (p = .88). We ran an additional analysis to compare
patients with “lateral” versus “medial” frontal lesions by
combining the patients with left and right lateral lesions into
one group. This did not alter the pattern of results.
DISCUSSION
Our ﬁndings show that the TMT-B is a reliable test for
detecting brain impairment. Both patients with frontal and
non-frontal lobe lesions performed worse than the neuro-
logically intact participants with regard to both efﬁciency and
accuracy. Critically however, completion time performance
on the TMT-B was not signiﬁcantly different between
the two patient groups. The presence or number of errors
performed during the task did not appear to provide any
0
20
40
60
80
100
120
140
Frontal Non-Frontal Healthy
Controls
C
om
pl
et
io
n 
Ti
m
e (
sec
on
ds
)
0
10
20
30
40
50
60
70
80
90
100
0 1 >1
%
 o
f P
ar
tic
ip
an
ts
Number of errors
Frontal Non-Frontal Healthy Control
(a) (b)
Fig. 1. Performance on the TMT-B for patients and healthy controls. (a) Mean completion time in seconds and 95% CI, and (b) the
number of errors.
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additional information. Non-frontal patients were equally
likely to make an error or more than one error on the task
compared with frontal patients. Furthermore, a small pro-
portion of neurologically intact participants also made an
error on the task. These results do not corroborate with that of
Stuss and colleagues (2001) who suggested that error analy-
sis could distinguish frontal from non-frontal lesions. This
could be due to the different composition of patient groups
between the two studies; the frontal patient group in the
previous study contained a large proportion of patients with
bilateral lesions. Our study corroborates with previous
studies that have shown no difference in performance
between frontal and non-frontal patients in TMT-B efﬁciency
(Demakis, 2004; Reitan & Wolfson, 1995; Tamez et al.,
2011) and extends this by demonstrating a lack of effect
similarly when examining the number of errors made.
We also found that TMT-B performance could not distin-
guish between different frontal lesion locations. Contrary
to previous suggestions that TMT-B performance might be
left lateralized (e.g., Moll et al., 2002) or localized to the
dorsolateral region (e.g., Stuss et al., 2001), we found no
signiﬁcant differences in performance between patients with
left and right frontal lesions or between patients with dorso-
lateral lesions compared with medial or orbital lesions. Our
ﬁndings suggest that TMT-B performance does not depend
on any speciﬁc frontal region.
Although our ﬁndings show that TMT-B performance
cannot distinguish patients with frontal and non-frontal focal
lesions, or between different sub-regions of the frontal lobe,
we are not suggesting that the TMT is a task that does not
require frontal lobe involvement. Rather, we suggest that
performance on the TMT-Bmost likely relies on a distributed
network involving both frontal and non-frontal regions.
Functional imaging has been one useful way of elucidating
underlying brain networks involved in performing the
TMT-B, although translation of the task into a design opti-
mized for imaging has its limitations. Nevertheless, recent
studies have consistently shown that successful performance
on the TMT-B involves not only frontal regions, but also
posterior and subcortical regions (Jacobson, Blanchard,
Connolly, Cannon, & Garavan, 2011; Zakzanis, Mraz, &
Graham, 2005).
From a clinical perspective, the TMT-B can offer many
insights regarding a patient’s cognitive abilities. However,
our ﬁndings suggest it may have limited utility as a tool in
detecting frontal executive dysfunction speciﬁcally as task
performance most likely depends upon a range of cognitive
processes, some of which require non-frontal brain regions.
As such, caution should be used when drawing conclusions
from TMT-B performance alone. Further work is needed to
establish whether current ﬁndings also extend to the various
alternate versions of the task (e.g., Oral or Color TMT).
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